Moringa oleifera leaf
PreclinicalSmall molecule
Moringa oleifera leaf is one of 7 small molecule programs targeting Gingivitis. It is currently in Preclinical.
2
Indications
5
Total Trials
2
Active Trials
6
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
6 competitors in Gingivitis
#DrugCompanyPhaseTrials
1Peridex
DDexcel Pharma Technologies Ltd.
Approved
Flagyl
DDePuy Orthopaedics
Approved
Combination
GSKPreclinical
Mouth Rinse
UUniversity of Pennsylvania
Phase 1
Moringa oleifera leaf
CCairo University
Preclinical
Essential Oils
UUniversity of Santiago de Compostela
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Nonvital Primary Molars2 trials
Evaluation of Moringa Oleifera Leaf Extract Versus Sodium Hypochlorite in Pulpectomy of Nonvital Primary Molars
Not yet recruiting·—·N/A·NCT06948526·50 enrolled
Moringa Oleifera vs Sodium Hypochlorite for Root Canal Irrigation in Nonvital Primary Molars
Not yet recruiting·—·N/A·NCT06971055·38 enrolled
Gingivitis1 trial
Anti-Plaque and Anti-Gingivitis Effects of Moringa Plant Extract and Fluoride Toothpastes
Unknown status·—·N/A·NCT05390099·60 enrolled
Otomycosis1 trial
Antifungal Potential of Moringa Olifera Against Otomycosis
Completed·—·Phase 1·NCT04768829·10 enrolled
Moringa Oleifera1 trial
Effect of Moringa Oleifera Capsule in Increasing Breast Milk Volume in Early Postpartum Patients
Completed·—·Phase 4·NCT04487613·88 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Moringa oleifera leaf. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- CCairo University